Skip to main content

Peer Review reports

From: Qin Huang formula enhances the effect of Adriamycin in B-cell lymphoma via increasing tumor infiltrating lymphocytes by targeting toll-like receptor signaling pathway

Original Submission
29 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 Mar 2022 Reviewed Reviewer Report
31 Mar 2022 Reviewed Reviewer Report
19 Apr 2022 Author responded Author comments - Weirong Zhu
Resubmission - Version 3
19 Apr 2022 Submitted Manuscript version 3
23 Apr 2022 Author responded Author comments - Weirong Zhu
Resubmission - Version 4
23 Apr 2022 Submitted Manuscript version 4
26 Apr 2022 Author responded Author comments - Weirong Zhu
Resubmission - Version 5
26 Apr 2022 Submitted Manuscript version 5
27 May 2022 Reviewed Reviewer Report
27 May 2022 Reviewed Reviewer Report
30 May 2022 Reviewed Reviewer Report
8 Jun 2022 Author responded Author comments - Weirong Zhu
Resubmission - Version 6
8 Jun 2022 Submitted Manuscript version 6
10 Jun 2022 Author responded Author comments - Weirong Zhu
Resubmission - Version 7
10 Jun 2022 Submitted Manuscript version 7
20 Jun 2022 Reviewed Reviewer Report
22 Jun 2022 Author responded Author comments - Weirong Zhu
Resubmission - Version 8
22 Jun 2022 Submitted Manuscript version 8
24 Jun 2022 Author responded Author comments - Weirong Zhu
Resubmission - Version 9
24 Jun 2022 Submitted Manuscript version 9
25 Jun 2022 Author responded Author comments - Weirong Zhu
Resubmission - Version 10
25 Jun 2022 Submitted Manuscript version 10
Publishing
29 Jun 2022 Editorially accepted
11 Jul 2022 Article published 10.1186/s12906-022-03660-8

You can find further information about peer review here.

Back to article page